Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 12/20 | 0.54 |
| ▸ | F2 | P00734 | 11/20 | 0.54 |
| ▸ | PLAU | P00749 | 10/20 | 0.54 |
| ▸ | PLAT | P00750 | 10/20 | 0.54 |
| ▸ | PLG | P00747 | 5/20 | 0.54 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.49 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.49 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.49 |
| ▸ | F7 | P08709 | 1/20 | 0.49 |
| ▸ | F3 | P13726 | 1/20 | 0.49 |
| ▸ | KLK1 | P06870 | 5/20 | 0.46 |
| ▸ | KLK5 | Q9Y337 | 4/20 | 0.46 |
| ▸ | NQO2 | P16083 | 1/20 | 0.45 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7663325 | 0.89 | F10 (0.55) | F10F2PLAUPLATPLG | |
| SCHEMBL7661613 | 0.88 | F10 (0.60) | F10F2PLAUPLATPLG | |
| SCHEMBL7663707 | 0.88 | F10 (0.54) | F10F2PLAUPLATPLG | |
| SCHEMBL7663682 | 0.88 | F10 (0.56) | F10F2PLAUPLATPLG | |
| SCHEMBL7663698 | 0.87 | F2 (0.57) | F10F2PLAUPLATPLG | |
| SCHEMBL7663318 | 0.87 | F2 (0.62) | F10F2PLAUPLATPLG | |
| SCHEMBL7659439 | 0.86 | F7 (0.64) | F10F2PLGPRSS1PRSS2 | |
| SCHEMBL7661279 | 0.84 | PLAU (0.62) | F10F2PLAUPLATPLG | |
| SCHEMBL7657755 | 0.83 | F2 (0.64) | F10F2PLAUPLATPLG | |
| SCHEMBL7850941 | 0.83 | F2 (0.63) | F10F2PLAUPLATPLG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6358960-B1 | FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-03-19 | — | — | US | disclosed |
| EP-1078917-A1 | AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-02-28 | — | — | EP | disclosed |